Ma et al.26 found that YTHDC2 is a powerful inducer of ferroptosis and that increasing YTHDC2 is an alternative therapy for lung adenocarcinoma targeting ferroptosis. The gene discussed is YTHDC2; the disease is lung adenocarcinoma.